Treasurer of the State of North Carolina Increases Stake in Amedisys, Inc. (NASDAQ:AMED)

Treasurer of the State of North Carolina lifted its position in Amedisys, Inc. (NASDAQ:AMEDFree Report) by 1.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,204 shares of the health services provider’s stock after acquiring an additional 140 shares during the quarter. Treasurer of the State of North Carolina’s holdings in Amedisys were worth $1,350,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in AMED. Pentwater Capital Management LP boosted its stake in shares of Amedisys by 239.5% during the third quarter. Pentwater Capital Management LP now owns 1,144,000 shares of the health services provider’s stock valued at $106,850,000 after purchasing an additional 807,000 shares in the last quarter. Norges Bank bought a new stake in Amedisys during the 4th quarter valued at $34,032,000. Segantii Capital Management Ltd purchased a new position in shares of Amedisys in the 4th quarter valued at $32,776,000. Bank of Nova Scotia bought a new position in shares of Amedisys in the 3rd quarter worth $26,671,000. Finally, AQR Arbitrage LLC lifted its stake in shares of Amedisys by 407.7% during the 3rd quarter. AQR Arbitrage LLC now owns 314,321 shares of the health services provider’s stock worth $29,358,000 after purchasing an additional 252,405 shares during the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Stock Up 0.3 %

AMED stock opened at $91.75 on Friday. The stock has a market capitalization of $3.00 billion, a PE ratio of -143.36, a price-to-earnings-growth ratio of 2.25 and a beta of 0.80. Amedisys, Inc. has a 52 week low of $89.55 and a 52 week high of $97.36. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.31. The firm has a 50 day moving average of $93.13 and a 200 day moving average of $93.66.

Amedisys (NASDAQ:AMEDGet Free Report) last posted its quarterly earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The business had revenue of $571.41 million during the quarter, compared to analysts’ expectations of $565.38 million. During the same quarter last year, the company posted $1.00 earnings per share. The business’s quarterly revenue was up 2.7% on a year-over-year basis. Sell-side analysts forecast that Amedisys, Inc. will post 4.57 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on AMED shares. Raymond James reiterated a “market perform” rating on shares of Amedisys in a report on Tuesday, March 26th. Royal Bank of Canada boosted their price objective on shares of Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, March 25th. StockNews.com upgraded shares of Amedisys from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $101.00 price target on shares of Amedisys in a report on Thursday, April 25th. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $100.80.

Read Our Latest Stock Report on Amedisys

About Amedisys

(Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Featured Stories

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys, Inc. (NASDAQ:AMEDFree Report).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.